AzTrials
AzTrials

All Adult Patients Admitted to theHMPIT ICU for Management of Head TraumaNCT05993312

Quality of Life in Traumatic Brain Injury Patients

An observational study of All Adult Patients Admitted to theHMPIT ICU for Management of Head Trauma, run by General Administration of Military Health, Tunisia at 2 sites in Tunisia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to describe the quality of life of CT patients in our study, at least 6 months after the occurrence of the trauma. This assessment is related to the patient's degree of sequelae, using the GOSE scale. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
quality of life
How many people
100 participants
Where
2 sitesTunisia
Study dates
1 Jun 2023to 30 Dec 2024
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Adult, Older adult

Study population: Collection of patients: medical data from the ICU medical record. Data collection of quality of life : outpatient clinic: the interview will be conducted by telephone. If number phone patient cannot be reached, the questionnaire will be sent by post to the patient's address

Who may be able to join

  • All adult patients (age 18 or over) admitted to the HMPIT intensive care unit for management of head trauma (isolated or as part of a polytrauma).

Who cannot join

  • Patients lost to follow-up after discharge. Incomplete ICU medical records. Patients or their families who refused to participate in the study.

Trial locations and contacts

2 sites in 1 country.

Aicha REBAI, FR contact

21671391133

aicha.rebai@fmt.utm.tn

Tunisia2 sites, 2 recruiting
  • Military Hospital of Tunis

    Tunis, Montfleury, 1008

    Hedi Gharsallah, MD, 71391885 ext. 00216, gharsallahhedi@gmail.com

    najla stambouli, PhD, 71391133 ext. 00216, nejlastam@gmail.com

    Recruiting
  • Service de réanimation

    Tunis, Montfleury, 1008

    Hedi Gharsallah, MD, 71390885 ext. 00216, gharsallahhedi@gmail.com

    Recruiting

Other trials in Tunisia

About this study

Official title: Quality of Life in Traumatic Brain Injury Patients: Assessment at Discharge From an Intensive Care Unit.

The aim of this study is to describe the quality of life of CT patients in our study, at least 6 months after the occurrence of the trauma. This assessment is related to the patient's degree of sequelae, using the GOSE scale.

Read the detailed description

The assessment of patients quality of life would appear to be a particularly relevant tool in the ongoing drive to improve the quality of care. Thus, we should no longer simply assess how patients "should feel", based on objective biomedical criteria, but how they actually "perceive" themselves, based on subjective criteria.

This is particularly true in the case of traumatic brain injury , which is a high-incidence pathology with significant morbidity and mortality consequences that can lead to permanent sequelae . While research over the past 30 years has focused on the neuropsychological and functional outcomes of this event, less is known about the views of head injury survivors and their families on their quality of life, subjective well-being and related factors.

The aim of this study is to describe the quality of life of CT patients at least 6 months after the trauma. This assessment is related to the patient's degree of sequelae, using the Glasgow Outcome Scale Extended GOSE.

Being tested
quality of life

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • quality of lifeOther

    To describe the relationship between distant sequelae of trauma assessed by the GOSE scale and quality of life

Study groups in NCT05993312
Study groupRoleWhat they receive
A bras actifNot described
Receives: Other: quality of life

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. quality of life in patients with BI / The short form12 SF12 questionnaire

    To describe the relationship between distant sequelae of trauma assessed by the GOSE scale and quality of life in patients with BI.

    Measured: 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2023
  2. Study start1 Jun 2023
  3. Primary completion30 Nov 2023 (estimated)
  4. Study completion30 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
100 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT05993312
Sponsor's protocol ID
QLTBIP
Status last verified
Aug 2023
First submitted
7 Aug 2023
Last updated
15 Aug 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of All Adult Patients Admitted to theHMPIT ICU for Management of Head Trauma, run by General Administration of Military Health, Tunisia at 2 sites in Tunisia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Aicha REBAI, FR (21671391133, aicha.rebai@fmt.utm.tn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

quality of life in patients with BI / The short form12 SF12 questionnaire (time frame: 6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in